Dengue virus transmission risk in blood donation: Evidence from Thailand
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.29689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Umaporn Limothai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Hauptthemen laut MEDLINE: Dengue, Blood Donors, Dengue Virus, Antibodies, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Tropical Medicine Cluster, Chulalongkorn University, Second Century Fund (C2F), Chulalongkorn University, Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University.
Abstract (Originalsprache)
Individuals infected with dengue virus (DENV) often show no symptoms, which raises the risk of DENV transfusion transmission (TT‐DENV) in areas where the virus is prevalent. This study aimed to determine the evidence of DENV infection in blood donors from different geographic regions of Thailand. A cross‐sectional study was conducted on blood donor samples collected from the Thai Red Cross National Blood Center and four regional blood centers between March and September 2020. Screening for DENV nonstructural protein 1 (NS1), anti‐DENV immunoglobulin G (IgG), and IgM antibodies was performed on residual blood from 1053 donors using enzyme‐linked immunosorbent assay kits. Positive NS1 and IgM samples indicating acute infection were verified using four different techniques, including quantitative real‐time (q) RT‐PCR, nested PCR, virus isolation in C6/36 cells, and mosquito amplification. DENV IgG seropositivity was identified in 89% (938/1053) of blood donors. Additionally, 0.4% (4/1053) and 2.1% (22/1053) of Thai blood donors tested positive for NS1 and IgM, respectively. The presence of asymptomatic dengue virus infection in healthy blood donors suggests a potential risk of transmission through blood transfusion, posing a concern for blood safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Tropical Medicine Cluster, Chulalongkorn University, Bangkok, Thailand.
- School of Global Health, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Thailand Public Health Research Fellowship, Health Education England, London, UK.
- Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University and Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
ORCID-Profile: Nattachai Srisawat
Förderung
- Tropical Medicine Cluster, Chulalongkorn University
- Second Century Fund (C2F), Chulalongkorn University
- Center of Excellence in Critical Care Nephrology, Faculty of Medicine, Chulalongkorn University
Zitieren
APA
Limothai, U., Tachaboon, S., Dinhuzen, J., Singh, J., Leewongworasingh, A., Watanaboonyongcharoen, P., Fernandez, S., Hunsawong, T., Farmer, A. R., Tantawichien, T., Thisyakorn, U., & Srisawat, N. (2024). Dengue virus transmission risk in blood donation: Evidence from Thailand. Journal of Medical Virology. https://doi.org/10.1002/jmv.29689
Vancouver
Limothai U, Tachaboon S, Dinhuzen J, Singh J, Leewongworasingh A, Watanaboonyongcharoen P, et al. Dengue virus transmission risk in blood donation: Evidence from Thailand. Journal of Medical Virology. 2024. doi:10.1002/jmv.29689
BibTeX
@article{Limothai2024,
author = {Limothai, Umaporn and Tachaboon, Sasipha and Dinhuzen, Janejira and Singh, Jasleen and Leewongworasingh, Akarathep and Watanaboonyongcharoen, Phandee and Fernandez, Stefan and Hunsawong, Taweewun and Farmer, Aaron R and Tantawichien, Terapong and Thisyakorn, Usa and Srisawat, Nattachai},
title = {Dengue virus transmission risk in blood donation: Evidence from Thailand},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.29689}
}
EUVIMED